Siegfried FY26 H1 core EBITDA rises 6% to CHF 142 million; net sales increase 2.2% to CHF 633 million

Reuters2026/08/21 04:21

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Siegfried posted first-half net sales of CHF 633 million, up 2.2% year on year, driven by higher Drug Substances sales.
Core EBITDA climbed 6% to CHF 142 million; margin widened 0.8 percentage points to 22.4%.
Core net profit rose 3.8% to CHF 68.2 million; core diluted EPS increased 4% to CHF 1.56.
Operating cash flow fell 37.4% to CHF 93.7 million; free cash flow dropped 62.6% to CHF 15.1 million.
Completed acquisition of three drug-substance sites effective May 1; confirmed FY 2026 outlook for high-single-digit local-currency sales growth.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Siegfried Holding AG published the original content used to generate this news brief on August 21, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Siegfried FY26 H1 core EBITDA rises 6% to CHF 142 million; net sales increase 2.2% to CHF 633 million

You may also like

Crypto prices